New York State Common Retirement Fund
XBI icon

New York State Common Retirement Fund’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

New York State Common Retirement Fund’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-11,566
Closed -$960K – 3234
2022
Q4 		$960K Buy
+11,566
New +$936K ﹤0.01% 1996

Other funds holding XBI

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

New York State Common Retirement Fund's XBI Position: Q1 2023 in Review

New York State Common Retirement Fund sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2023, closing a stake of 11,566 shares — an estimated $960K sold.

New York State Common Retirement Fund first reported a position in XBI in Q4 2022 and held it in 1 quarter. The position peaked at $960K in Q4 2022. 713 funds tracked by Wall St. Rank hold XBI as of Q1 2023.

  • New York State Common Retirement Fund reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2023 after selling out during the quarter.
  • New York State Common Retirement Fund sold 11,566 State Street SPDR S&P Biotech ETF shares in Q1 2023, an estimated $960K.
  • New York State Common Retirement Fund first reported a position in State Street SPDR S&P Biotech ETF in Q4 2022 and held it in 1 quarter.
  • New York State Common Retirement Fund's State Street SPDR S&P Biotech ETF position peaked at $960K in Q4 2022.
  • 713 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2023.

Based on New York State Common Retirement Fund's 13F filing for Q1 2023, filed 2 May 2023.